- Kemwell BioPharma, India’s largest biologics CDMO, has implemented the Veeva Vault Quality Management System (QMS) across its operations.
- The adoption of Veeva Vault QMS will support Kemwell’s vision of rapid expansion across 40 countries worldwide.
Kemwell BioPharma, India’s largest biologics contract development and manufacturing organisation (CDMO), has announced the implementation of the Veeva Vault Quality Management System (QMS) across its development and manufacturing operations.
Deepak Gupta, vice president of quality at Kemwell, said, “Veeva is a trusted partner for quality management, and adopting its industry-leading solutions will provide the foundation to execute toward our vision of rapid expansion across 40 countries worldwide.” He further added that Veeva Vault QMS will play a pivotal role in helping them achieve regulatory compliance.
The Vault QMS features pre-configured QMS processes based on industry best practices. This will enable Kemwell to drive efficiency and quality in its operations. By using a quality system on a cloud-based platform, Kemwell will foster seamless collaboration with stakeholders while ensuring greater transparency across customers, auditors, and regulatory agencies.
This transition to a modern QMS aims to enhance the company’s quality processes and further its leadership in biologics contract development and manufacturing. Varadarajan Srinivasan, general manager, Veeva Vault Quality India, expressed pride in partnering with Kemwell to support their digital quality transformation.
Overview of outsourcing trends 
